Response Genetics Inc (RGDXQ)
0.00
USD |
OTCM |
Apr 24, 16:00
Response Genetics Cash from Financing (TTM): 9.922M for March 31, 2015
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2015 | 1.258M |
December 31, 2014 | -0.195M |
September 30, 2014 | 65.02M |
June 30, 2014 | 58.63M |
March 31, 2014 | 58.12M |
December 31, 2013 | 58.11M |
September 30, 2013 | 1.544M |
June 30, 2013 | 8.624M |
March 31, 2013 | 8.585M |
December 31, 2012 | 16.30M |
September 30, 2012 | 17.31M |
June 30, 2012 | 8.536M |
March 31, 2012 | 10.80M |
December 31, 2011 | 3.128M |
September 30, 2011 | 2.225M |
Date | Value |
---|---|
June 30, 2011 | 2.259M |
March 31, 2011 | 0.0795M |
December 31, 2010 | 3.954M |
September 30, 2010 | 3.898M |
June 30, 2010 | 7.941M |
March 31, 2010 | 7.941M |
December 31, 2009 | 6.062M |
September 30, 2009 | 6.062M |
June 30, 2009 | 2.00M |
March 31, 2009 | 2.00M |
December 31, 2008 | 0.00 |
September 30, 2008 | 0.395M |
June 30, 2008 | 0.3782M |
March 31, 2008 | 17.59M |
December 31, 2007 | 17.59M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (TTM) Benchmarks
Perspective Therapeutics Inc | 0.785M |
Electromed Inc | -0.128M |
Xtant Medical Holdings Inc | 19.69M |
Asensus Surgical Inc | 9.626M |
Vitro Biopharma Inc (DELISTED) | 1.619M |